Gentian Diagnostics AS (GENT) - Total Liabilities

Latest as of December 2025: Nkr53.58 Million NOK ≈ $5.64 Million USD

Based on the latest financial reports, Gentian Diagnostics AS (GENT) has total liabilities worth Nkr53.58 Million NOK (≈ $5.64 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Gentian Diagnostics AS net asset momentum to track the company's year-over-year net asset growth rate.

Gentian Diagnostics AS - Total Liabilities Trend (2013–2025)

This chart illustrates how Gentian Diagnostics AS's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Gentian Diagnostics AS to measure how efficiently the company converts operating cash flow to free cash.

Gentian Diagnostics AS Competitors by Total Liabilities

The table below lists competitors of Gentian Diagnostics AS ranked by their total liabilities.

Company	Country	Total Liabilities
Inmobiliaria Manquehue S.A SN:MANQUEHUE	Chile	CL$185.96 Billion
Ta Yih Industrial Co Ltd TW:1521	Taiwan	NT$1.11 Billion
Queenco-L TA:QNCO	Israel	ILA67.13 Million
Duroc AB (publ) ST:DURC-B	Sweden	Skr970.50 Million
MCT Bhd KLSE:5182	Malaysia	RM550.59 Million
Taeyang Metal KO:004100	Korea	₩432.99 Billion
Sekar Bumi Tbk JK:SKBM	Indonesia	Rp1.06 Trillion
Jinhui Shipping and Transportation Limited F:J4O	Germany	€169.47 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Gentian Diagnostics AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GENT company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.40	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	3.10	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Gentian Diagnostics AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Gentian Diagnostics AS (2013–2025)

The table below shows the annual total liabilities of Gentian Diagnostics AS from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	Nkr53.58 Million ≈ $5.64 Million	+50.45%
2024-12-31	Nkr35.61 Million ≈ $3.75 Million	+3.52%
2023-12-31	Nkr34.40 Million ≈ $3.62 Million	+2.33%
2022-12-31	Nkr33.62 Million ≈ $3.54 Million	-9.19%
2021-12-31	Nkr37.02 Million ≈ $3.90 Million	-9.00%
2020-12-31	Nkr40.69 Million ≈ $4.28 Million	+114.78%
2019-12-31	Nkr18.94 Million ≈ $1.99 Million	+56.47%
2018-12-31	Nkr12.11 Million ≈ $1.27 Million	+38.29%
2017-12-31	Nkr8.75 Million ≈ $921.24K	+18.00%
2016-12-31	Nkr7.42 Million ≈ $780.68K	+51.53%
2015-12-31	Nkr4.90 Million ≈ $515.21K	-58.78%
2014-12-31	Nkr11.88 Million ≈ $1.25 Million	-5.36%
2013-12-31	Nkr12.55 Million ≈ $1.32 Million	--

About Gentian Diagnostics AS

OL:GENT Norway Medical Devices

Market Cap

$60.37 Million

Nkr573.71 Million NOK

Market Cap Rank

#21139 Global

#190 in Norway

Share Price

Nkr37.20

Change (1 day)

-7.46%

52-Week Range

Nkr34.60 - Nkr59.20

All Time High

Nkr86.00